Remove tag investors
article thumbnail

Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

The Pharma Data

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com. Investor Contacts: Christopher DelOrefice (732) 524-2955. Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories.

article thumbnail

Johnson & Johnson to Participate in Wells Fargo 2020 Virtual Healthcare Conference

The Pharma Data

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com. Investor Contacts: Jennifer McIntyre (732) 524-3922. Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference

The Pharma Data

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com. Investor Contacts: Lisa Romanko (732) 524-2034. Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories.

article thumbnail

Johnson & Johnson to Participate in the 18th Annual Morgan Stanley Virtual Global Healthcare Conference

The Pharma Data

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com. Investor Contacts: Christopher DelOrefice (732) 524-2955. Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories.

article thumbnail

Johnson & Johnson to Participate in Bernstein’s 37th Annual Strategic Decisions Virtual Conference

The Pharma Data

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com. Investor Contacts: Christopher DelOrefice (732) 524-2955. Remarketing tags may not be associated with personally identifiable information or placed on pages related to sensitive categories.

article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

Wall Street wants growth, as do investors, but that may be impossible for pharmaceutical companies. In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies.

article thumbnail

Biogen’s Aduhelm rollout goes from bad to worse

pharmaphorum

Vounatsos also insisted that Aduhelm’s price tag has not been a factor discouraging treatment with the drug. Pushback from doctors in particular is causing anxiety for investors, as that may not be affected much if CMS opts to approve reimbursement, and shares in the company fell a little over 6% following the results announcement.

Sales 122